Cardiology Fiesta 2017
Avatar

Renal, Metabolic and Cardiovascular Considerations of SGLT2 Inhibition

By Cardiology Fiesta 2017 FEATURING Ralph DeFronzo
By Cardiology Fiesta 2017 FEATURING Ralph DeFronzo
9,386 views
November 10, 2017
7 Comments
Login to view comments. Click here to Login

Featured Video

18:06
Lilly Obesity

Getting Patients Started with an Obesity Treatment Option for Adults

Feat. E. Lazarus

Related Content

AUTOPLAY
64:45
Symposium on Diabetes and Cancer 2017: Novel Links and Treatments

Primer on Diabetes Management

Feat. S. Inzucchi
11:37
ACC 2022 Conference Coverage

ACC 2022: An Embarrassment of Riches - Updated Guideline Recommendat…

Feat. P. Heidenreich
11:25
ACC 2023 Conference Coverage

ACC 2023: SGLT2i Use - Dos and Don'ts

Feat. A. Armbruster
18:43
ASPC 2019 Congress on CVD Prevention

Diabetes Treatment Guidelines Finally Have Entered the 21st Century …

Feat. R. DeFronzo
15:06
Robert Busch

GLP-1/GIP Update: Stay Tuned... The Best is Yet to Come!!

37:21
University of Colorado Department of Medicine

Evidence that Obesity and Diabetes are Driven by a Diet-Induced Biol…

Feat. R. Johnson
17:44
Rita Jermyn

SGLT2 Inhibitors: For Heart Failure, Diabetes, and Renal Disease

27:24
Cardiometabolic Health Congress (CMHC)

SGLT2 Inhibitors, GLP1 Receptor Agonists, and Renal Outcomes

Feat. L. Sloan
31:46
ACC 2024 Insights

ACC 2024 Insights: Evolving Pharmacology for HFrEF vs. HFpFF - With …

Feat. M. Costanzo
14:19
UChicago Medicine

S-QUAD Therapy and Beyond: HFpEF in 2024

Feat. M. Belkin
19:30
ACC 2022 Conference Coverage

Hot Topics in Heart Failure ACC.22

Feat. N. Ibrahim
10:02
Emory Diabetes Education Training Academy

Insulin Treatment in Patients with Type 2 Diabetes: When to Use Comb…

Feat. G. Umpierrez
13:42
George Bakris

Current Status of Prevention and Treatment of Diabetic Nephropathy

13:43
Stanford Medicine

What's the Ideal Therapy for Obesity?

Feat. A. Yeoh
34:04
The Texas Heart Institute

Use of Finerenone in Patients with Diabetes Who Have Kidney Disease

Feat. G. Bakris
11:50
American Heart & Vascular Institute

New Medications for Heart Failure: SGLT2 Inhibitors and Vericiguat. …

Feat. M. Kittleson
27:52
Top Ten Topics in Clinical Cardiology 2023

Medical Management of Diastolic Dysfunction: Does The Emperor Finall…

Feat. S. Pinney
22:48
Scripps Health

Heart Failure with Preserved Ejection Fraction: New Treatments

Feat. R. C. Mohan
14:02
Georgia Heart Institute

Heart Failure Therapies

Feat. U. Egolum, H. Samady
15:25
Javed Butler

SGLT2 Inhibitors and Heart Failure in Type-2 Diabetes Mellitus